Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion) Acquisition expands Merck... ...http://businesswireindia.com/news/news-details/merck-acquire-sigma-aldrich-enhance-position-attractive-life-science-i/40801
The first rule for the small investor is don't risk capital you can't afford to lose. We're in a very good biotech market right now, and I expect... ...http://www.commodityonline.com/news/how-can-investors-tap-potential-of-small-life-sciences-companies-59945-3-59946.html
Sankar Sundaram, pharmaceutical sciences professor at JSS University, Mysore and a patent agent with India's intellectual property office, counters... ...http://pharma.financialexpress.com/sections/management/4428-analysing-reactions-to-india-s-draft-pharma-patent-g-lines
The Scripps Research Institute have discovered and synthesized a new drug candidate for relapsing multiple sclerosis. According to the results... ...http://www.medindia.net/news/drug-candidate-for-multiple-sclerosis-shows-new-promise-141551-1.htm
A military-sponsored programme in the US known as Electrical Prescriptions or ElectRx aims to develop the device so tiny that it can be implanted... ...http://post.jagran.com/tiny-implants-to-heal-organs-of-human-body-1411370883
Indian Association of Preventive &...